Last reviewed · How we verify
WR 279,396 with Gauze and Tape Dressing — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
WR 279,396 with Gauze and Tape Dressing (WR 279,396 with Gauze and Tape Dressing) — U.S. Army Medical Research and Development Command.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| WR 279,396 with Gauze and Tape Dressing TARGET | WR 279,396 with Gauze and Tape Dressing | U.S. Army Medical Research and Development Command | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- WR 279,396 with Gauze and Tape Dressing CI watch — RSS
- WR 279,396 with Gauze and Tape Dressing CI watch — Atom
- WR 279,396 with Gauze and Tape Dressing CI watch — JSON
- WR 279,396 with Gauze and Tape Dressing alone — RSS
Cite this brief
Drug Landscape (2026). WR 279,396 with Gauze and Tape Dressing — Competitive Intelligence Brief. https://druglandscape.com/ci/wr-279-396-with-gauze-and-tape-dressing. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab